Screening test combo suggested for NAFLD fibrosis

GPs and all specialists managing patients with metabolic risk factors could be screening for clinically significant fibrosis associated with non-alcoholic fatty liver disease (NAFLD), Queensland researchers say. A study of patients with NAFLD and attending either a type 2 diabetes clinic at a major Brisbane hospital or an integrated primary-secondary care diabetes service identified clinically ...

Already a member?

Login to keep reading.

© 2021 the limbic